AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Byline: Rupa Damodaran
BIOCON Ltd, one of India's billion-dollar biotechnology companies, will be investing RM500 million in a biomanufacturing and research and development facility in Malaysia.
Its chairman and managing director Kiran Mazumdar-Shaw said the facility in Bio-XCell, in Iskandar Malaysia, will start operating by 2014.
"We plan to put a large facility in the first phase to manufacture a range of insulin products - a high-tech biomanufacturing facility that includes a research facility side by side.
"This project is expected to start almost immediately and we hope the first phase will be completed in the next three to four years," she …